Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012–2014, a retrospective analysis
Highlights • We assessed the agreement between the recommendations and the final reimbursement decisions in Poland in years 2012–2014. • The compliance between the type of recommendation of the TB and the President of the Agency was 95%. • A significant discrepancy between positive recommendations a...
Gespeichert in:
| Veröffentlicht in: | Health policy (Amsterdam) 2016-11, Vol.120 (11), p.1240-1248 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1248 |
|---|---|
| container_issue | 11 |
| container_start_page | 1240 |
| container_title | Health policy (Amsterdam) |
| container_volume | 120 |
| creator | Kawalec, Paweł Malinowski, Krzysztof Piotr |
| description | Highlights • We assessed the agreement between the recommendations and the final reimbursement decisions in Poland in years 2012–2014. • The compliance between the type of recommendation of the TB and the President of the Agency was 95%. • A significant discrepancy between positive recommendations and final reimbursement decisions was also observed. • We observed an increasing share of positive-conditional recommendations; the introduction of RSS was the most common. |
| doi_str_mv | 10.1016/j.healthpol.2016.09.021 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1853741522</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0168851016302676</els_id><sourcerecordid>1931697302</sourcerecordid><originalsourceid>FETCH-LOGICAL-c454t-df992f0030193ed53fa5c69e30c216b3b2e389e9fcf515b8e54b96a34d1873053</originalsourceid><addsrcrecordid>eNqNks9u1DAQxiMEokvhFSASlx5I8J84iS9IqwooUiUQlLPlOJOulyRePNlKuXHmyhvyJEx2S5F64jSW_ZvPM_NNkrzgLOeMl6-3-QZsP212oc8FXeRM50zwB8mK15XISqaKh8mKHuqsVpydJE8Qt4yxSsrycXIiaiZ0wdUq-fkZejv58Tq9OAimV-A2Y-jD9ZyuEQFxgHFKI7gw0KklNoyY2rGlOz80-4hwIFpwHg9vfkw_hX4h6DSDjZhSieL3j18UileppcwpBtyBm_wNkJbtZ_T4NHnU2R7h2W08Tb6-e3t1fpFdfnz_4Xx9mblCFVPWdlqLjjHJuJbQKtlZ5UoNkjnBy0Y2AmStQXeuU1w1Naii0aWVRUujkUzJ0-TsqLuL4fsecDKDRwc9lQxhj4bXSlY0HCEIfXkP3YZ9pHqJ0pKXmgQXqjpSjrrCCJ3ZRT_YOBvOzGKX2Zo7u8xil2HakF2U-fxWf98M0N7l_fWHgPURABrIjYdo0HkYHbSeLJlMG_x_fPLmnobr_eid7b_BDPivI4PCMPNl2ZplaXhJzZVVKf8AFfPA4g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1931697302</pqid></control><display><type>article</type><title>Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012–2014, a retrospective analysis</title><source>MEDLINE</source><source>PAIS Index</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kawalec, Paweł ; Malinowski, Krzysztof Piotr</creator><creatorcontrib>Kawalec, Paweł ; Malinowski, Krzysztof Piotr</creatorcontrib><description>Highlights • We assessed the agreement between the recommendations and the final reimbursement decisions in Poland in years 2012–2014. • The compliance between the type of recommendation of the TB and the President of the Agency was 95%. • A significant discrepancy between positive recommendations and final reimbursement decisions was also observed. • We observed an increasing share of positive-conditional recommendations; the introduction of RSS was the most common.</description><identifier>ISSN: 0168-8510</identifier><identifier>EISSN: 1872-6054</identifier><identifier>DOI: 10.1016/j.healthpol.2016.09.021</identifier><identifier>PMID: 28029415</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>AOTMiT ; Compliance ; Data collection ; Decision Making ; Drugs ; Health administration ; Health Policy ; Health Technology Assessment ; Humans ; Influence ; Internal Medicine ; Measurement ; Medical technology ; Ministry of Health ; Poland ; Polish Agency for Health Technology Assessment and Tariff System ; Presidents ; Reimbursement Mechanisms - economics ; Reimbursement system ; Retrospective Studies ; Risk assessment ; Risk sharing ; Studies ; Technology assessment ; Technology Assessment, Biomedical ; Transparency</subject><ispartof>Health policy (Amsterdam), 2016-11, Vol.120 (11), p.1240-1248</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2016 Elsevier Ireland Ltd</rights><rights>Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Nov 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c454t-df992f0030193ed53fa5c69e30c216b3b2e389e9fcf515b8e54b96a34d1873053</citedby><cites>FETCH-LOGICAL-c454t-df992f0030193ed53fa5c69e30c216b3b2e389e9fcf515b8e54b96a34d1873053</cites><orcidid>0000-0002-0125-0947</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.healthpol.2016.09.021$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27865,27923,27924,30998,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28029415$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawalec, Paweł</creatorcontrib><creatorcontrib>Malinowski, Krzysztof Piotr</creatorcontrib><title>Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012–2014, a retrospective analysis</title><title>Health policy (Amsterdam)</title><addtitle>Health Policy</addtitle><description>Highlights • We assessed the agreement between the recommendations and the final reimbursement decisions in Poland in years 2012–2014. • The compliance between the type of recommendation of the TB and the President of the Agency was 95%. • A significant discrepancy between positive recommendations and final reimbursement decisions was also observed. • We observed an increasing share of positive-conditional recommendations; the introduction of RSS was the most common.</description><subject>AOTMiT</subject><subject>Compliance</subject><subject>Data collection</subject><subject>Decision Making</subject><subject>Drugs</subject><subject>Health administration</subject><subject>Health Policy</subject><subject>Health Technology Assessment</subject><subject>Humans</subject><subject>Influence</subject><subject>Internal Medicine</subject><subject>Measurement</subject><subject>Medical technology</subject><subject>Ministry of Health</subject><subject>Poland</subject><subject>Polish Agency for Health Technology Assessment and Tariff System</subject><subject>Presidents</subject><subject>Reimbursement Mechanisms - economics</subject><subject>Reimbursement system</subject><subject>Retrospective Studies</subject><subject>Risk assessment</subject><subject>Risk sharing</subject><subject>Studies</subject><subject>Technology assessment</subject><subject>Technology Assessment, Biomedical</subject><subject>Transparency</subject><issn>0168-8510</issn><issn>1872-6054</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>7TQ</sourceid><recordid>eNqNks9u1DAQxiMEokvhFSASlx5I8J84iS9IqwooUiUQlLPlOJOulyRePNlKuXHmyhvyJEx2S5F64jSW_ZvPM_NNkrzgLOeMl6-3-QZsP212oc8FXeRM50zwB8mK15XISqaKh8mKHuqsVpydJE8Qt4yxSsrycXIiaiZ0wdUq-fkZejv58Tq9OAimV-A2Y-jD9ZyuEQFxgHFKI7gw0KklNoyY2rGlOz80-4hwIFpwHg9vfkw_hX4h6DSDjZhSieL3j18UileppcwpBtyBm_wNkJbtZ_T4NHnU2R7h2W08Tb6-e3t1fpFdfnz_4Xx9mblCFVPWdlqLjjHJuJbQKtlZ5UoNkjnBy0Y2AmStQXeuU1w1Naii0aWVRUujkUzJ0-TsqLuL4fsecDKDRwc9lQxhj4bXSlY0HCEIfXkP3YZ9pHqJ0pKXmgQXqjpSjrrCCJ3ZRT_YOBvOzGKX2Zo7u8xil2HakF2U-fxWf98M0N7l_fWHgPURABrIjYdo0HkYHbSeLJlMG_x_fPLmnobr_eid7b_BDPivI4PCMPNl2ZplaXhJzZVVKf8AFfPA4g</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>Kawalec, Paweł</creator><creator>Malinowski, Krzysztof Piotr</creator><general>Elsevier B.V</general><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7TQ</scope><scope>8BJ</scope><scope>DHY</scope><scope>DON</scope><scope>FQK</scope><scope>JBE</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0125-0947</orcidid></search><sort><creationdate>20161101</creationdate><title>Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012–2014, a retrospective analysis</title><author>Kawalec, Paweł ; Malinowski, Krzysztof Piotr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c454t-df992f0030193ed53fa5c69e30c216b3b2e389e9fcf515b8e54b96a34d1873053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>AOTMiT</topic><topic>Compliance</topic><topic>Data collection</topic><topic>Decision Making</topic><topic>Drugs</topic><topic>Health administration</topic><topic>Health Policy</topic><topic>Health Technology Assessment</topic><topic>Humans</topic><topic>Influence</topic><topic>Internal Medicine</topic><topic>Measurement</topic><topic>Medical technology</topic><topic>Ministry of Health</topic><topic>Poland</topic><topic>Polish Agency for Health Technology Assessment and Tariff System</topic><topic>Presidents</topic><topic>Reimbursement Mechanisms - economics</topic><topic>Reimbursement system</topic><topic>Retrospective Studies</topic><topic>Risk assessment</topic><topic>Risk sharing</topic><topic>Studies</topic><topic>Technology assessment</topic><topic>Technology Assessment, Biomedical</topic><topic>Transparency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawalec, Paweł</creatorcontrib><creatorcontrib>Malinowski, Krzysztof Piotr</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>PAIS Index</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>MEDLINE - Academic</collection><jtitle>Health policy (Amsterdam)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawalec, Paweł</au><au>Malinowski, Krzysztof Piotr</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012–2014, a retrospective analysis</atitle><jtitle>Health policy (Amsterdam)</jtitle><addtitle>Health Policy</addtitle><date>2016-11-01</date><risdate>2016</risdate><volume>120</volume><issue>11</issue><spage>1240</spage><epage>1248</epage><pages>1240-1248</pages><issn>0168-8510</issn><eissn>1872-6054</eissn><abstract>Highlights • We assessed the agreement between the recommendations and the final reimbursement decisions in Poland in years 2012–2014. • The compliance between the type of recommendation of the TB and the President of the Agency was 95%. • A significant discrepancy between positive recommendations and final reimbursement decisions was also observed. • We observed an increasing share of positive-conditional recommendations; the introduction of RSS was the most common.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>28029415</pmid><doi>10.1016/j.healthpol.2016.09.021</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-0125-0947</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0168-8510 |
| ispartof | Health policy (Amsterdam), 2016-11, Vol.120 (11), p.1240-1248 |
| issn | 0168-8510 1872-6054 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1853741522 |
| source | MEDLINE; PAIS Index; Applied Social Sciences Index & Abstracts (ASSIA); ScienceDirect Journals (5 years ago - present) |
| subjects | AOTMiT Compliance Data collection Decision Making Drugs Health administration Health Policy Health Technology Assessment Humans Influence Internal Medicine Measurement Medical technology Ministry of Health Poland Polish Agency for Health Technology Assessment and Tariff System Presidents Reimbursement Mechanisms - economics Reimbursement system Retrospective Studies Risk assessment Risk sharing Studies Technology assessment Technology Assessment, Biomedical Transparency |
| title | Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012–2014, a retrospective analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A22%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relating%20Health%20Technology%20Assessment%20recommendations%20and%20reimbursement%20decisions%20in%20Poland%20in%20years%202012%E2%80%932014,%20a%20retrospective%20analysis&rft.jtitle=Health%20policy%20(Amsterdam)&rft.au=Kawalec,%20Pawe%C5%82&rft.date=2016-11-01&rft.volume=120&rft.issue=11&rft.spage=1240&rft.epage=1248&rft.pages=1240-1248&rft.issn=0168-8510&rft.eissn=1872-6054&rft_id=info:doi/10.1016/j.healthpol.2016.09.021&rft_dat=%3Cproquest_cross%3E1931697302%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1931697302&rft_id=info:pmid/28029415&rft_els_id=1_s2_0_S0168851016302676&rfr_iscdi=true |